Advancing
beyond the twitch
The first quantitative TOF monitor powered by TetraGraph® Adaptive Intelligence™ for industry leading precision and ease of use
Orders will begin shipping in the United States in Q4.
The first quantitative TOF monitor powered by TetraGraph® Adaptive Intelligence™ for industry leading precision and ease of use
Orders will begin shipping in the United States in Q4.
Senzime is a pioneering medical device company specializing in precision-based patient monitoring systems.
Our mission is to safeguard every patient’s journey, from anesthesia to recovery.
Setting a new standard in intelligent, quantitative train-of-four (TOF) monitoring, through these unique features:
Note: Orders will begin shipping in the United States in Q4. The device will be available in selected markets in Europe starting in 2025, with expansion into other regions contingent upon obtaining the necessary regulatory clearances and market readiness.
We provide more than cutting-edge technology. Our commitment extends to helping you excel with resources and support tailored to your needs.
Learn about the latest clinical guidelines, get started with quantitative TOF monitoring, and access valuable insights to improve patient outcomes.
An industry shift through a unique sustainable approach
Senzime stands at the forefront of the healthcare industry with a distinct sustainable approach. Our core strategy is rooted deeply in sustainability, ingrained in every facet of our operations.
Our goal is clear: to be the industry leader in sustainable monitoring solutions and the preferred partner for healthcare systems seeking long-term sustainable commitments.
Patient monitoring devices for monitoring neuromuscular blockade and respiratory function during and after surgery.
We're here to support you in elevating your practice. Start today by reading a blog, watching a video or a webinar.
A leading medical device company on a global mission to safeguard every patient's journey, from anesthesia to recovery.
We are on a mission to revolutionize perioperative care for 100 million patients globally.